EP3917556 - USE OF IGFBP7 FOR TREATING MALARIA [Right-click to bookmark this link] | Status | Request for examination was made Status updated on 05.11.2021 Database last updated on 18.10.2024 | |
Former | The international publication has been made Status updated on 08.08.2020 | Most recent event Tooltip | 23.01.2024 | New entry: Renewal fee paid | Applicant(s) | For all designated states Agency for Science, Technology and Research 1 Fusionopolis Way 20-10, Connexis North Tower Singapore 138632 / SG | [2021/49] | Inventor(s) | 01 /
LEE, Wenn-Chyau c/o Singapore Immunology Network 8a Biomedical Grove Level 3 Immunos Building Singapore 138648 / SG | 02 /
RENIA, Laurent c/o Singapore Immunology Network 8a Biomedical Grove Level 3 Immunos Building Singapore 138648 / SG | [N/P] |
Former [2021/49] | 01 /
LEE, Wenn-Chyau Singapore 138648 / SG | ||
02 /
RENIA, Laurent Singapore 138648 / SG | Representative(s) | Murgitroyd & Company 165-169 Scotland Street Glasgow G5 8PL / GB | [N/P] |
Former [2021/49] | Mitchell, Simon James Urquhart-Dykes & Lord LLP Euston House 24 Eversholt Street London NW1 1AD / GB | Application number, filing date | 20747994.0 | 30.01.2020 | [2021/49] | WO2020SG50043 | Priority number, date | SG20191000872X | 30.01.2019 Original published format: SG10201900872X | [2021/49] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2020159444 | Date: | 06.08.2020 | Language: | EN | [2020/32] | Type: | A1 Application with search report | No.: | EP3917556 | Date: | 08.12.2021 | Language: | EN | The application published by WIPO in one of the EPO official languages on 06.08.2020 takes the place of the publication of the European patent application. | [2021/49] | Search report(s) | International search report - published on: | SG | 06.08.2020 | (Supplementary) European search report - dispatched on: | EP | 13.07.2022 | Classification | IPC: | A61K38/17, A61P33/06, A61K38/37, A61K38/39, A61K45/06 | [2022/32] | CPC: |
A61K45/06 (EP);
A61K38/36 (US);
A61K31/137 (US);
A61K31/155 (US);
A61K31/357 (US);
A61K31/366 (US);
A61K31/4706 (US);
A61K31/4709 (US);
A61K31/506 (US);
A61K31/635 (US);
A61K31/65 (US);
A61K38/1754 (EP);
A61K38/18 (US);
A61K38/37 (EP);
A61K38/39 (EP);
| C-Set: |
A61K38/1754, A61K2300/00 (EP);
A61K38/37, A61K2300/00 (EP);
A61K38/39, A61K2300/00 (EP)
|
Former IPC [2021/49] | A61K38/17, A61P33/06 | Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2021/49] | Title | German: | VERWENDUNG VON IGFBP7 ZUR BEHANDLUNG VON MALARIA | [2021/49] | English: | USE OF IGFBP7 FOR TREATING MALARIA | [2021/49] | French: | UTILISATION DE L'IGFBP7 POUR TRAITER LE PALUDISME | [2021/49] | Entry into regional phase | 26.08.2021 | National basic fee paid | 26.08.2021 | Search fee paid | 26.08.2021 | Designation fee(s) paid | 26.08.2021 | Examination fee paid | Examination procedure | 26.08.2021 | Examination requested [2021/49] | 02.02.2023 | Amendment by applicant (claims and/or description) | Fees paid | Renewal fee | 21.12.2021 | Renewal fee patent year 03 | 31.01.2023 | Renewal fee patent year 04 | 23.01.2024 | Renewal fee patent year 05 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [A]WO2010113146 (MEDICAL RES INFRASTRUCTURE AND [IL], et al); | International search | [A]WO2009036188 (UNIV MASSACHUSETTS [US], et al); | [A]WO2009099378 (FORSKARPATENT I SYD AB [SE], et al); | [A]US9592271 (PURCELL NGAMBO LISA ARLEEN [US], et al); | [A]US2018127752 (LIU PETER [CA], et al); |